Form 8-K - Current report:
SEC Accession No. 0001193125-22-144294
Filing Date
2022-05-09
Accepted
2022-05-09 07:38:32
Documents
14
Period of Report
2022-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d359035d8k.htm   iXBRL 8-K 25505
2 EX-99.1 d359035dex991.htm EX-99.1 63299
6 GRAPHIC g359035g0506230514844.jpg GRAPHIC 3510
  Complete submission text file 0001193125-22-144294.txt   228725

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vrca-20220509.xsd EX-101.SCH 2856
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrca-20220509_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrca-20220509_pre.xml EX-101.PRE 11707
8 EXTRACTED XBRL INSTANCE DOCUMENT d359035d8k_htm.xml XML 3443
Mailing Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380
Business Address 10 NORTH HIGH STREET SUITE 200 WEST CHESTER PA 19380 484-453-3300
Verrica Pharmaceuticals Inc. (Filer) CIK: 0001660334 (see all company filings)

EIN.: 463137900 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38529 | Film No.: 22903262
SIC: 2834 Pharmaceutical Preparations